Collegium Pharma
Presence
Collegium Pharma is one of the...
Collegium Pharma is a company listed under the stock ticker COLL (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Collegium Pharma
- Michael Heffernan, Interim President and Chief Executive Officer
- Neil McFarlane, Director
- Gwen Melincoff, Director
Popular executive movements at Collegium Pharma
- Michael Heffernan has joined the company as Interim President and Chief Executive Officer (posted on May 10 2024).
- Joseph Ciaffoni, Director, President and Chief Executive Officer, has left the company (posted on May 10 2024).
Create your alert
to follow the executive moves at Collegium Pharma.
Pharmaceuticals
Collegium Pharma has 1,860 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Collegium Pharma
- Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022 - Collegium Pharmaceutical Inc.
- Collegium to Participate in H.C. Wainwright Global Investment Conference - Collegium Pharmaceutical Inc.
- Collegium Reports First Quarter 2022 Financial Results - Collegium Pharmaceutical Inc.
- Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results - Collegium Pharmaceutical Inc.
- Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation - Collegium Pharmaceutical Inc.
- Collegium Appoints Rita Balice-Gordon to its Board of Directors - Collegium Pharmaceutical Inc.
- Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference - Collegium Pharmaceutical Inc.
- Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference - Collegium Pharmaceutical Inc.
- Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020 - Collegium Pharmaceutical Inc.
- Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update - Collegium Pharmaceutical Inc.
- View more press releases Close
Social media about Collegium Pharma
- Collegium Pharma on Wikipedia, Google News & Yahoo Finance
- Collegium Pharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Thomas Smith 
Call Collegium Pharma at +1 781...
